Broadfin Capital, LLC, 10% Owner at Recro Pharma, Inc. (REPH), sold 222,616 shares at $9.68 ($2.1M) on 2017-11-29, disclosed to the SEC on 2017-11-30.
Open-market sale of $2.1M REPH by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.56 | 21,619 | $207K | 9.7% |
| 2 | $9.68 | 1,500 | $15K | 0.7% |
| 3 | $9.71 | 24,430 | $237K | 11.1% |
| 4 | $9.66 | 3,764 | $36K | 1.7% |
| 5 | $9.68 | 700 | $7K | 0.3% |
| 6 | $9.68 | 2,200 |
| $21K |
| 1.0% |
| 7 | $9.55 | 100,000 | $955K | 44.8% |
| 8 | $9.55 | 50,000 | $478K | 22.4% |
| 9 | $9.61 | 100 | $961 | 0.0% |
| 10 | $9.62 | 5,000 | $48K | 2.3% |
| 11 | $9.63 | 6,322 | $61K | 2.9% |
| 12 | $9.69 | 500 | $5K | 0.2% |
| 13 | $9.71 | 6,381 | $62K | 2.9% |
| 14 | $9.71 | 100 | $971 | 0.0% |
| Total | $9.58 avg | 222,616 | $2.1M | 100% |
| Filing → |
| BDSI | SELL | 2019-05-14 | $9.0M | — | Filing → |
| REPH | SELL | 2018-05-24 | $1.1M | — | Filing → |
| REPH | SELL | 2018-03-15 | $2.0M | — | Filing → |